Journal
BREAST CANCER RESEARCH
Volume 5, Issue 1, Pages 37-41Publisher
BMC
DOI: 10.1186/bcr553
Keywords
breast cancer; genomic instability; mouse model; telomerase; telomere
Categories
Funding
- NCI NIH HHS [KO8CA82176, K08 CA082176] Funding Source: Medline
- NATIONAL CANCER INSTITUTE [K08CA082176] Funding Source: NIH RePORTER
Ask authors/readers for more resources
Telomerase - an enzyme that endows cells with unlimited proliferative potential - is differentially expressed in cancer cells and in normal cells. Although most primary human cells lack telomerase, the enzyme is upregulated in more than 90% of invasive breast cancers. As a result, much of breast cancer development occurs before telomerase is reactivated during a critical transition from a telomerase-negative to a telomerase-positive state. During this transition, the telomere shortening that accompanies cell division may either prevent or facilitate tumorigenesis by activating checkpoints and impairing chromosomal stability. In mature cancers, telomerase probably serves a crucial role in tumor progression and maintenance by stabilizing telomeres and supporting the immortal growth of breast cancer cells.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available